Strides Shasun gets DCGI nod to manufacture Hepatitis C drug

By: | Published: December 21, 2015 4:42 PM

The company has received approval for manufacturing a generic version of Sofosbuvir 400 mg, Strides Shasun today said in a filing to BSE.

Dr Reddy's LabSofosbuvir is the first-in-class polymerase inhibitor to be launched in India for Hepatitis C treatment and represents “a paradigm shift” in the existing Hepatitis C cure. (Reuters photo)

Drug firm Strides Shasun has received approval from the Drug Controller General of India (DCGI) to produce a generic version of Gilead’s ‘Sovaldi’ used for treatment of Hepatitis C.

The company has received approval for manufacturing a generic version of Sofosbuvir 400 mg, Strides Shasun today said in a filing to BSE.

Last year, Strides had entered into a licensing agreement with Gilead Sciences to bring Hepatitis C cure to 91 developing countries.

“The product will continue to be marketed under the brand name Virso in India and overseas,” Strides Shasun said.

Sofosbuvir is the first-in-class polymerase inhibitor to be launched in India for Hepatitis C treatment and represents “a paradigm shift” in the existing Hepatitis C cure, it added.

“The high potency, high barrier to resistance and pan genotype activity make Sofosbuvir a breakthrough drug in Hepatitis C treatment. This drug in combination therapy has shown to have high cure rates of around 90 per cent,” it said.

Globally, it is estimated that 170-185 million people are chronically infected with Hepatitis C virus. In India alone, it is estimated that 12-18 million patients are infected with the disease, which is several fold higher than those with HIV/AIDS.

Shares of the company were trading at Rs 1,311.75 apiece on BSE, up 0.42 per cent from the previous close.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition